Tudor Investment Corp
DNTH icon

Tudor Investment Corp’s Dianthus Therapeutics DNTH Stock Holding History

Tudor Investment Corp’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.64M Buy
+37,308
New +$3.26M 0.01% 1508
2020
Q4 		– Sell
-1,842
Closed -$200K – 1386
2020
Q3 		$200K Sell
1,842
-296
-14% -$35.1K 0.01% 1137
2020
Q2 		$257K Buy
+2,138
New +$301K 0.01% 929
2018
Q3 		– Sell
-625
Closed -$135K – 1115
2018
Q2 		$135K Buy
+625
New +$141K ﹤0.01% 966

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

Tudor Investment Corp's DNTH Position: Q2 2026 in Review

Tudor Investment Corp opened a new position in Dianthus Therapeutics (DNTH) in Q2 2026: 37,308 shares worth $3.64M. The stake represents 0.01% of the portfolio and ranks #1508 among its holdings. This is a return to the name: Tudor Investment Corp previously reported a position in DNTH as recently as Q3 2020.

Tudor Investment Corp first reported a position in DNTH in Q2 2018 and has held it in 4 quarters since. 270 funds tracked by Wall St. Rank hold DNTH as of Q2 2026.

  • Tudor Investment Corp held 37,308 shares of Dianthus Therapeutics worth $3.64M as of Q2 2026.
  • Dianthus Therapeutics was a new Tudor Investment Corp position in Q2 2026.
  • Dianthus Therapeutics made up 0.01% of Tudor Investment Corp's portfolio in Q2 2026, its #1508 holding.
  • Tudor Investment Corp first reported a position in Dianthus Therapeutics in Q2 2018 and has held it in 4 quarters since.
  • 270 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.